A monoclonal antibody drug combo showed promise in lowering viral loads in early-stage COVID-19 outpatients,

The 501Y.V2 SARS-CoV-2 variant identified in South Africa has researchers worried it could bypass protection from prior infection or vaccination,

“COVID camouflagers”—those who have hidden their condition entirely— have manifold reasons for their coverups.  

Doctors say they help. So why are COVID-19 treatments—including monoclonal antibodies, antivirals, and corticosteroids—going unused?

The long weekend was a busy one for vaccine news—here’s the latest:

The arrival of the first wave of COVID-19 vaccines brings hope to a battered, weary world that 2021 can be the beginning of the end of a devastating, still-raging pandemic. But while the fight against this terrible disease has showcased an impressive array of global health…

Deploying new vaccines has always been a messy business of logistical hurdles, ethical questions, and amazing feats.   Take the first-ever vaccine campaign, Spain’s 19th century effort to stamp out smallpox in its far flung colonies.

A Chinese-made coronavirus vaccine has an efficacy rate just over 50%—far lower than the 78% anticipated, according to a Brazilian clinical trial conducted by São Paulo’s Butantan Institute.  

WHO investigators from 9 countries have arrived in Wuhan to look into the origins of the pandemic, following delays that triggered a rare rebuke from the agency.  

The issue is far from settled among economists and politicians, as NPR repor